Truist Securities analyst Supawat Thongthip assumes coverage on Arcus Biosciences (NYSE: RCUS) with a Buy rating and a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage